ecancermedicalscience

ecancermedicalscience is an open access cancer journal focused on under-resourced communities. In order to help reduce global inequalities in cancer care and treatment, we provide free access to all articles from the point of publication and we only charge authors who have specific funding to cover publication costs.

The journal considers articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epidemiology, clinical reports, controlled trials (in particular if they are independent or publicly funded trials), health systems, cancer policy and regulatory aspects of cancer care.

Editor-in-Chief: Dr Eduardo Cazap, MD PhD (President SLACOM)

ISSN: 1754-6605

Submit article

1190-a-review-of-breast-cancer-pathology-reports-in-nigeria

Research: A review of breast cancer pathology reports in Nigeria

Adedayo O Joseph, Ya-Huei Li, Omolola Salako, Suhail Doi, Onyinye D Balogun, Opeyemi M Awofeso, Fatimah Abdulkareem, Adedayo A Onitilo

23 Feb 2021

https://doi.org/10.3332/ecancer.2021.1190

Abstract | Full Article | PDF

1189-national-approaches-to-managing-cancer-care-responses-of-countries-in-the-mena-region-to-the-covid-19-pandemic

Research: National approaches to managing cancer care: responses of countries in the MENA region to the COVID-19 pandemic

Zineb Benbrahim, Layth Mula-Hussain, Humaid O Al-Shamsi, Nagi El Saghir, Mushabbab Al Asiri, Bassim Al Bahrani, Muath Al Nassar, Adda Bounedjar, Zahera Fahed, Sami Khatib, Ola Khorshid, Soumaya Labidi, Nawfel Mellas, Amani Saleh, Abdulrahman Jazieh

23 Feb 2021

https://doi.org/10.3332/ecancer.2021.1189

Abstract | Full Article | PDF

1188-chemotherapy-induced-neutropenia-and-febrile-neutropenia-among-breast-cancer-patients-in-a-tertiary-hospital-in-nigeria

Research: Chemotherapy induced neutropenia and febrile neutropenia among breast cancer patients in a tertiary hospital in Nigeria

Omolola Salako, Kehinde Sharafadeen Okunade, Adeoluwa Akeem Adeniji, Gabriel Timilehin Fagbenro, Oluwasegun Joshua Afolaranmi

15 Feb 2021

https://doi.org/10.3332/ecancer.2021.1188

Abstract | Full Article | PDF

1187-the-threat-of-the-covid-19-pandemic-on-reversing-global-life-saving-gains-in-the-survival-of-childhood-cancer-a-call-for-collaborative-action-from-siop-ipso-pros-wcc-cci-st-jude-global-uicc-and-whpca

Policy: The threat of the COVID-19 pandemic on reversing global life-saving gains in the survival of childhood cancer: a call for collaborative action from SIOP, IPSO, PROS, WCC, CCI, St Jude Global, UICC and WHPCA

Kathy Pritchard-Jones, Simone de C V Abib, Natia Esiashvili, Gertjan J L Kaspers, Jon Rosser, Jon A Van Doorninck, João ML Braganca, Ruth I Hoffman, Carlos Rodriguez-Galindo, Cary Adams, Stephen R Connor, Abdelhafeez H Abdelhafeez, Eric Bouffet, Scott C Howard, Julia M Challinor, Laila Hessissen, Rashmi B Dalvi, Pamela Kearns, Guillermo L Chantada, Lindsay A Frazier, Michael J Sullivan, Fiona SM Schulte, Lisa K Morrissey, Olga Kozhaeva, Sandra Luna-Fineman, Muhammad S Khan

15 Feb 2021

https://doi.org/10.3332/ecancer.2021.1187

Abstract | Full Article | PDF

1186-primary-mediastinal-germ-cell-tumours-real-world-experience-in-the-low-middle-income-lmic-setting

Research: Primary mediastinal germ cell tumours: real world experience in the low middle income (LMIC) setting

Anjana Joel, Namrata Mathew, Shalom Sylvester Andugala, Sherin Daniel, Birla Roy Gnanamuthu, Ajoy Oommen John, Josh Thomas Georgy, Raju Titus Chacko, Aparna Irodi, Bijesh Yadav, Subhashini John, Ashish Singh

11 Feb 2021

https://doi.org/10.3332/ecancer.2021.1186

Abstract | Full Article | PDF